These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12118457)

  • 1. In vitro effect of antifungal drugs on pathogenic Naegleria spp.
    Tiewcharoen S; Junnu V; Chinabut P
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):38-41. PubMed ID: 12118457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antifungal drugs on pathogenic Naegleria spp isolated from natural water sources.
    Tiewcharoen S; Junnu V; Suvoutho S
    J Med Assoc Thai; 2003 Sep; 86(9):876-82. PubMed ID: 14649973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A; Sancak B; Arikan S
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
    Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole].
    Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT
    Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
    Goswick SM; Brenner GM
    J Parasitol; 2003 Aug; 89(4):837-42. PubMed ID: 14533700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.
    Abdel-Salam HA
    Mycoses; 2005 Sep; 48(5):327-32. PubMed ID: 16115103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
    Schuster FL; Guglielmo BJ; Visvesvara GS
    J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic amoebae: challenges in prophylaxis and treatment.
    Schuster FL; Visvesvara GS
    Drug Resist Updat; 2004 Feb; 7(1):41-51. PubMed ID: 15072770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro interactions of micafungin with amphotericin B, itraconazole or fluconazole against the pathogenic phase of Penicillium marneffei.
    Cao C; Liu W; Li R; Wan Z; Qiao J
    J Antimicrob Chemother; 2009 Feb; 63(2):340-2. PubMed ID: 19054803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.
    Gualco L; Debbia EA; Bandettini R; Pescetto L; Cavallero A; Ossi MC; Schito AM; Marchese A
    Int J Antimicrob Agents; 2007 Feb; 29(2):179-84. PubMed ID: 17175140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activities of azole agents against the Malassezia species.
    Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
    Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antifungal resistance: an emerging problem in Mexico].
    Manzano-Gayosso P; Méndez-Tovar LJ; Hernández-Hernández F; López-Martínez R
    Gac Med Mex; 2008; 144(1):23-6. PubMed ID: 18619054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
    Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
    Li L; Wang Z; Li R; Luo S; Sun X
    Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
    Swinne D; Watelle M; Van der Flaes M; Nolard N
    Mycoses; 2004 Jun; 47(5-6):177-83. PubMed ID: 15189180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.